FDA Scrutinizes Pfizer Study Evaluating Chantix Suicide Risks
The U.S. Food and Drug Administration (FDA) is questioning whether or not Pfizer’s study of neuropsychiatric effects of Chantix, the smoking cessation drug, accurately reflects the risks. Pfizer conducted the clinical trial upon request from the FDA, following a high rate of suicidal thoughts linked to Chantix. The study also … [Read more...]
Merck Hid Suicide Risks with Propecia, Lawsuit Alleges
A lawsuit has been filed in California federal court on behalf of a widow whose husband committed suicide after using the hair loss drug Propecia. It is the first suit of its kind, and was filed on March 5 in California's Southern District. Allegedly, Merck failed to warn that Propecia can lead to suicidal thoughts and … [Read more...]
Chantix Suicide Risk Warrants Black Box Warning, Consumer Group Says
Chantix Suicide Risk Black Box Warning. Chantix, the smoking cessation drug linked to suicidal behavior and other psychiatric problems, should bear the Food & Drug Administration's (FDA) strongest safety warning, the consumer group Public Citizen says. Earlier this year, warnings of suicide and other behavioral problems seen in … [Read more...]
Ottawa Warns of Suicide Risk For Teens On Anti-Depressants
Anti-Depressants Increase The Risk Of Suicide. Mounting concerns over the safety of prescribing a new generation of anti-depressants to children and teenagers has prompted Health Canada to issue a rare public warning to reconsider their use because the popular drugs may actually increase the risk of suicide. In an … [Read more...]